Long-term antibody-response monitoring following primary exposure to SARS-COV-2 and afterward mRNA COVID-19 vaccination: A case report

Balint, Bela (7005347355)Bela (7005347355)BalintBalint, Milena Todorovic (57140127400)Milena Todorovic (57140127400)BalintAndric, Zorana (23033104600)Zorana (23033104600)AndricJovicic, Milica (56915792700)Milica (56915792700)JovicicBlagojevic, Glorija (57223138084)Glorija (57223138084)BlagojevicColic, Miodrag (20933591700)Miodrag (20933591700)Colic2025-06-122025-06-122021https://doi.org/10.2298/VSP200220019Bhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85104967590&doi=10.2298%2fVSP200220019B&partnerID=40&md5=48973610a97f811a3e1084df1dbc4464https://remedy.med.bg.ac.rs/handle/123456789/4500[No abstract available]AntibodiesCovid-19Covid-19 serotherapyInfectionsVaccinationLong-term antibody-response monitoring following primary exposure to SARS-COV-2 and afterward mRNA COVID-19 vaccination: A case report